D-1585-2019 Class III Terminated

Recalled by AAA Pharmaceutical, Inc. — Lumberton, NJ

FDA drug recall D-1585-2019 was initiated by AAA Pharmaceutical, Inc. on Jun 25, 2019 and is designated Class III. Reason for recall: Labeling; Incorrect or Missing Lot Number and/or Exp Date; Product has an incorrect expiration date of 9/2022 applied to the labeling, where the actual expiration date is 10/2021. The recall status is terminated (terminated Dec 16, 2020). Affected quantity: a) 288 bottles b) 48 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 14, 2019
Initiation Date
Jun 25, 2019
Termination Date
Dec 16, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 288 bottles b) 48 bottles

Product description

Smart Sense Regular Strength Aspirin Tablets, 325 mg packed in a) 100 count UPC 8-8397-38781-6 and b) 500 count UPC 8-83967-38786-1 bottles, Distributed by: Kmart Corporation Hoffman Estates, IL 60179

Reason for recall

Labeling; Incorrect or Missing Lot Number and/or Exp Date; Product has an incorrect expiration date of 9/2022 applied to the labeling, where the actual expiration date is 10/2021.

Distribution pattern

KS

Code information

a) P136370, exp 9/2022 b) P136366, exp 9/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1585-2019
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for AAA Pharmaceutical, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-1585-2019. Report a data issue: hello@regdatalab.com.